OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells remains a paramount challenge for the biopharmaceutical industry. Various strategies have been employed enhance antibody titer, comprising process parameter optimization, genetic engineering, and the use of perfusion systems. Fine-tuning culture condition